VANCOUVER, BC, Jan. 21, 2025 ~ Las Vegas, NV - Human in Motion Robotics, a global leader in robotic mobility and humanoid technology, has made a groundbreaking leap in the field of rehabilitation technology with their latest product, XoMotion™. This innovative medical exoskeleton was recently named the Top Robot at CES 2025 by USA Today.

CES 2025, held from January 7-10 in Las Vegas, brought together the brightest minds in technology to showcase cutting-edge innovations from around the world. Among these impressive displays was XoMotion, which received widespread recognition from attendees, media outlets, and industry leaders for its transformative potential to assist individuals with mobility impairments caused by spinal cord injuries, strokes, and other neurological conditions.

The success of Human in Motion Robotics' exhibition at CES 2025 was highlighted by several key achievements. XoMotion received accolades from visitors and industry leaders alike, including a CES 2025 Innovations Award that solidified its position as a shining example of human-centered technological innovation. Attendees were also able to experience firsthand the self-balancing, hands-free, and natural motion capabilities of XoMotion through product demonstrations. These demonstrations were attended by individuals with mobility challenges as well as therapists and physicians who were impressed by the exoskeleton's ability to empower users with independence and enhance care.

More on nvtip.com

• Nespolo Mechanical Helps New Mexico Families Save Thousands on Heating Costs This Fall
• Gig Workers on Netverse Will Enjoy Maximum Flexibility and Direct Control Over Their Pricing and Scheduling, All While Earning Rewards From Phinge
• DevLearn Returns Featuring Signature DemoFest and a New, Major Learning Tech Meetup
• Leading Digital Finance Platform YNQTL Launches Revolutionary Web3 Digital Asset Trading Platform
• IDCXS Addresses Crypto Trading Pain Points with 2 Million TPS Processing and Multi-Layer Security Architecture

Investors and partners were also engaged by the platform technology and multidisciplinary expertise of Human in Motion Robotics. This led to exciting opportunities for future growth and advancements for XoMotion beyond just rehabilitation purposes.

The event also marked another milestone for Human in Motion Robotics as they continue to make strides towards improving the lives of those with mobility impairments. The connections made during CES will drive future advancements and growth for the company.

One of the key highlights of the exhibition was meeting Chloë Angus, Product Ambassador & Director of Lived Experience at Human in Motion Robotics. Chloë's inspiring journey of overcoming adversity serves as a testament to the power of XoMotion. After a life-altering medical event, Chloë partnered with HMR to help develop XoMotion, leveraging her lived experience to ensure the exoskeleton truly addresses the needs of users.

For those interested in learning more about XoMotion and Human in Motion Robotics, interviews with Chloë or a full press kit can be requested by contacting Phil Astrachan, VP of Marketing at 415-310-7466.

XoMotion's innovative design and functionality redefine assistive technology. The exoskeleton provides hands-free, self-balancing support that mimics natural human movement, making it intuitive for patients to use while reducing the physical and cognitive strain on therapists.

More on nvtip.com

• Bridging Traditional Finance and Web3 Innovation: BLFCW Announces Strategic Vision for Regulated Web3 Economy
• NKSCX Responds to "Coordinated Smear Campaign" as Anonymous Critics Emerge Following Regulatory Milestones
• Broadway Gala Honored Also an Italian
• $ONI Listed on MEXC as ONINO Powers Europe's Tokenization Engine Into Public Platform Launch
• AZETHIO Crypto Exchange Whitepaper Reveals MPC-Secured Infrastructure Processing 1.2 Million Transactions Per Second

Some key features of XoMotion include its self-balancing capabilities, which ensure stability and safety during use with 12 high-performance actuators that replicate natural bipedal movement. It also allows for hands-free upper-body functionality, enhancing usability. The exoskeleton is capable of complex ambulatory tasks and offers true functionality in all directions. Designed to aid patients at various stages of recovery, including spinal cord injuries, strokes, and other neurological impairments, XoMotion is also therapist-friendly as it reduces physical strain on therapists and allows them to focus on patient care.

Human in Motion Robotics is committed to making XoMotion accessible to those who need it most. Currently available for acquisition by rehabilitation facilities in Canada, the device is also available for scientific investigators conducting rehabilitation or robotics research worldwide. Clinical trials are currently underway for FDA approval in the United States with plans to expand its reach to other global markets such as Europe and Asia.

For more information or to request a demonstration of XoMotion, please visit humaninmotion.com or contact Human in Motion Robotics directly through their website.

---

Show All News | Report Violation